These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38235832)

  • 21. Comparison of intravenous and subcutaneous exposure supporting dose selection of subcutaneous belimumab systemic lupus erythematosus Phase 3 program.
    Yapa SW; Roth D; Gordon D; Struemper H
    Lupus; 2016 Nov; 25(13):1448-1455. PubMed ID: 27072354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combatting the Rising Tide of Antimicrobial Resistance: Pharmacokinetic/Pharmacodynamic Dosing Strategies for Maximal Precision.
    Chua HC; Tse A; Smith NM; Mergenhagen KA; Cha R; Tsuji BT
    Int J Antimicrob Agents; 2021 Mar; 57(3):106269. PubMed ID: 33358761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease.
    Golpanian S; Schulman IH; Ebert RF; Heldman AW; DiFede DL; Yang PC; Wu JC; Bolli R; Perin EC; Moyé L; Simari RD; Wolf A; Hare JM;
    Stem Cells Transl Med; 2016 Feb; 5(2):186-91. PubMed ID: 26683870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The natural history of prescription opioid abuse: A pilot study exploring change in routes of administration and motivation for changes.
    McCaffrey S; Manser KA; Trudeau KJ; Niebler G; Brown C; Zarycranski D; Budman SH
    J Opioid Manag; 2018; 14(6):397-405. PubMed ID: 30629276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338).
    Petricoul O; Nazarian A; Schuehly U; Schramm U; David OJ; Laurent D; Praestgaard J; Roubenoff R; Papanicolaou DA; Rooks D
    Clin Pharmacokinet; 2023 Jan; 62(1):141-155. PubMed ID: 36527600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerability and Pharmacokinetics of Contezolid at Therapeutic and Supratherapeutic Doses in Healthy Chinese Subjects, and Assessment of Contezolid Dosing Regimens Based on Pharmacokinetic/Pharmacodynamic Analysis.
    Wu J; Wu H; Wang Y; Chen Y; Guo B; Cao G; Wu X; Yu J; Wu J; Zhu D; Guo Y; Yuan H; Hu F; Zhang J
    Clin Ther; 2019 Jun; 41(6):1164-1174.e4. PubMed ID: 31126694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of Therapeutic Proteins for a New Subcutaneous Route of Administration After the Establishment of Intravenous Dosages: A Systematic Review.
    Xu Z; Leu JH; Xu Y; Nnane I; Liva SG; Wang-Lin SX; Kudgus-Lokken R; Vermeulen A; Ouellet D
    Clin Pharmacol Ther; 2023 May; 113(5):1011-1029. PubMed ID: 36516352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Modeling of Weight-Based Intravenous Reslizumab Dosing.
    Passarell J; Jaworowicz D; Ludwig E; Rabinovich-Guilatt L; Cox DS; Levi M; Garin M; Fiedler-Kelly J; Bond M
    J Clin Pharmacol; 2020 Aug; 60(8):1039-1050. PubMed ID: 32333684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Supportive Evidence for US Food and Drug Administration Approvals of Novel Drugs in 2020.
    Mitra-Majumdar M; Gunter SJ; Kesselheim AS; Brown BL; Joyce KW; Ross M; Pham C; Avorn J; Darrow JJ
    JAMA Netw Open; 2022 May; 5(5):e2212454. PubMed ID: 35579897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric pharmacology: current efforts and future goals to improve clinical practice.
    Krekels EH; Tibboel D; Knibbe CA
    Expert Opin Drug Metab Toxicol; 2015; 11(11):1679-82. PubMed ID: 26166262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison between European Medicines Agency and US Food and Drug Administration in Granting Accelerated Marketing Authorizations for Covid-19 Medicines and their Utilized Regulations.
    Ghadanian M; Schafheutle E
    Ther Innov Regul Sci; 2024 Jan; 58(1):79-113. PubMed ID: 37861859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.
    Chen ML
    Clin Pharmacokinet; 2006; 45(10):957-64. PubMed ID: 16984210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of pharmacokinetic-pharmacodynamic relationships in drug development].
    Bellissant E; Courcier-Duplantier S; Blin O;
    Therapie; 2002; 57(4):347-57. PubMed ID: 12422555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury.
    Cota JM; FakhriRavari A; Rowan MP; Chung KK; Murray CK; Akers KS
    Clin Ther; 2016 Sep; 38(9):2016-31. PubMed ID: 27586127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility Breakpoints.
    Bhavnani SM; Trang M; Griffith DC; Lomovskaya O; Hammel JP; Loutit JS; Cammarata SK; Dudley MN; Ambrose PG; Rubino CM
    Antimicrob Agents Chemother; 2022 Dec; 66(12):e0213021. PubMed ID: 36374023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How modeling and simulation have enhanced decision making in new drug development.
    Miller R; Ewy W; Corrigan BW; Ouellet D; Hermann D; Kowalski KG; Lockwood P; Koup JR; Donevan S; El-Kattan A; Li CS; Werth JL; Feltner DE; Lalonde RL
    J Pharmacokinet Pharmacodyn; 2005 Apr; 32(2):185-97. PubMed ID: 16283534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timing and Characteristics of Cumulative Evidence Available on Novel Therapeutic Agents Receiving Food and Drug Administration Accelerated Approval.
    Naci H; Wouters OJ; Gupta R; Ioannidis JPA
    Milbank Q; 2017 Jun; 95(2):261-290. PubMed ID: 28589600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-dose pharmacokinetics of temocillin in plasma and soft tissues of healthy volunteers after intravenous and subcutaneous administration: a randomized crossover microdialysis trial.
    Matzneller P; Ngougni Pokem P; Capron A; Lackner E; Wulkersdorfer B; Nussbaumer-Pröll A; Österreicher Z; Duchek M; Van de Velde S; Wallemacq PE; Mouton JW; Van Bambeke F; Zeitlinger M
    J Antimicrob Chemother; 2020 Sep; 75(9):2650-2656. PubMed ID: 32433753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Riluzole in Spinal Cord Injury Study (RISCIS)-Pharmacokinetic (PK) Sub-Study: An Analysis of Pharmacokinetics, Pharmacodynamics, and Impact on Axonal Degradation of Riluzole in Patients With Traumatic Cervical Spinal Cord Injury Enrolled in the RISCIS Phase III Randomized Controlled Trial.
    Chow DS; Nguyen A; Park J; Wu L; Toups EG; Harrop JS; Guest JD; Schmitt KM; Aarabi B; Fehlings MG; Boakye M; Grossman RG
    J Neurotrauma; 2023 Sep; 40(17-18):1889-1906. PubMed ID: 37130044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.